References

1. Webber HJ. History and development of the citrus industry. In: Reuther W, Webber HJ, Batchelor LD, eds., The Citrus Industry, vol. I. Berkeley: University of California Press, 1967, pp. 1-39.

2. Webber HJ. Cultivated varieties of the citrus. In: Webber HJ, Batchelor DL, eds., The Citrus Industry, vol. I. Berkeley: University of California Press, 1943, pp. 475-668.

3. Facciola S, Cornucopia II, eds. A Source Book of Edible Plants. Vista: Kampong Publications, 1998.

4. Hosseinimehr SJ, Tavakoli H, Pourheirdari G, Sobhani A, Shafiee A. Radioprotec-tive effects of citrus extract agains gamma-irradiation in mouse bone marrow cells. J Radiat Res 2003;44:237-241.

5. Kiple KF, Ornelas KC, eds. The Cambridge World History of Food. Cambridge: Cambridge University Press, Vol. 2, 2000, pp. 1822-1826.

6. Ramadan W, Mourad B, Ibrahim S, Sonbol F. Oil of bitter orange: new topical antifungal agent. Int J Dermatol 1996;35:448-449.

7. Natural Medicines Comprehensive Database online. www.naturaldatabase.com. Date accessed: June 15, 2006.

8. FDA Drug Information. www.fda.gov/cder/drug/infopage/ppa/. Date accessed June 15 2006.

9. Department of Health and Human Services, Food and Drug Administration 2004;1-363. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. www.fda.gov/OHRMS/ D0CKETS/98fr/1995n-0304-nfr0001.pdf. Date accessed: June 15, 2006.

10. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-1545.

11. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-1838.

12. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003;138:468-471.

13. Marcus DM, Grollman AP. Ephedra-free is not danger free. Science 2003;301:1667-1671.

14. Preuss HG, DiFerdinando D, Bagchi M, Bagchi D. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. J Med 2002;33(1-4):247-264.

15. Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med 2004;229:698-704.

16. Bent S, Padula A, Neuhaus J. Safety and efficacy of Citrus aurantium for weight loss. Am J Cardiol 2004;94:1359-1361.

17. United States Patent and Trademark Office. www.uspto.gov/patft. Search terms: citrus and aurantium. Date accessed: June 15, 2006.

18. Pellati F, Benvenuti S, Melegari M, Firenzuoli F. Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var by LC. J Pharm Biomed Anal 2002;29:1113-1119.

19. Pellati F, Benvenuti S, Melegari M. High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara. Phytochem Anal 2004;15:220-225.

20. Andrea GD, Terrazzino S, Fortin D, Farruggio A, Rinaldi L, Leon A. HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes. Neurosci Lett 2003;346:89-92.

21. Boulton AA. Trace amines: comparative and clinical neurobiology. In: Juorio AV, Downer RGH, eds. Experimental and Clinical Neuroscience. Totowa, NJ: Humana, 1988.

22. Pellati F, Benvenuti S, Melegari M. Enantioselective LC analysis of synephrine in natural products on a protein-based chiral stationary phase. J Pharm Biomed Anal 2005;37(5):839-849.

23. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds., Goodman and Gilman's the Pharmacologic Basis for Therapeutics, 10th edition. New York, McGraw Hill: 2001, pp. 215-268.

24. Williams CM, Couch MW, Thonoor CM, Midgley JM. Isomeric octopamines: their occurrence and functions. J Pharm Pharmacol 1987;39:153-157.

25. Hwa J, Perez DM. The unique nature of the serine interactions for a1-adrenergic receptor agonist binding and activation. J Biol Chem 1996;271(11):6322-6327.

26. Brown CM, McGrath JC, Midgley JM, et al. Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Br J Pharmacol 1988;93:417-429.

27. Airriess CN, Rudling JE, Midgley JM, Evans PD. Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoreceptor. Br J Pharmacol 1997;12(2):191-198.

28. Jordan R, Midgley JM, Thonoor CM, Williams CM. Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. J Pharm Pharmacol 1987;39(9):752-754.

29. Liapakis G, Balesteros JA, Papachristou S, Chan WC, Chen X, Javitch JA. The forgotten serine: a critical role for Ser-203 in ligand binding to and activation of the ß2-adrenergic receptor. J Biol Chem 2000;275(48):37,779-37,788.

30. Carpene C, Galitzky J, Fontana E, Atgie C, Lafontan MB. Selective activation of ß3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Arch Pharmacol 1999;359(4):310-321.

31. Huang YT, Wang GF, Chen CF, Chen CC, Hong CY, Yang MCM. Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci 1995;57:2011-2020.

32. Calapai G, Firenzuoli F, Saitta A, et al. Antiobesity and cardiovascular effects of Citrus aurantium extraces in the rat: a preliminary report. Fitoterapia 1999;70:586-592.

33. Huang YT, Lin HC, Chang YY, Yang YY, Lee SD, Hong CY. Hemodynamic effects of synephrine treatment in portal hypertensive rats. Jpn J Pharmacol 2001;85:183-188.

34. Hofstetter R, Kreuder J, von Bernuth G. The effect of oxedrine on the left ventricle and peripheral vascular resistance. Arzneimittelforschung 1985;12:1844-1846.

35. Penzak SR, Jann MW, Cold A, Hon YY, Desai HD, Gurley BJ. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol 2001;41:1059-1063.

36. Colker CM, Kalman DS, Torina GC, Perlis T, Street C. Effects of Citrus aurantium extract, caffeine, and St. John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res 1999;60:145-153.

37. Kaddu S, Kerl H, Wolf P. Accidental bullous phototoxic reactions to bergamot aromatherapy oil. J Am Acad Dermatol 2001;45(3):458-461.

38. Zaynoun ST, Aftimos BA, Tenekjian KK, Kurban AK. Berloque dermatitis — a continuing cosmetic problem. Contact Dermatitis 1981;7(2):111-116.

39. Chew A, Maibach H. Berloque Dermatitison. eMedicine 2001. www.emedicine. com/derm/topic52.htm. Date accessed: June 15, 2006.

40. Makki S, Treffel P, Humbert P, Agache P. High-performance liquid chromato-graphic determination of citropten and bergapten in suction blister fluid after solar product application in humans. J Chromatogr 1991;563:407-413.

41. Clark SM, Wilkinson SM. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil. Contact Dermatitis 1998;38:289-290.

42. Levine N, Don S, Owens C, Rogers DT, Kligman AM, Forlot P. The effects of bergapten and sunlight on cutaneous pigmentation. Arch Dermatol 1989;125:1225-1230.

43. Ashwood-Smith MJ, Poulton GA, Barker M, Mildenberger M. 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal mutagenic and clastogenic properties. Nature 1980;285:407-409.

44. Nykamp DL, Fackih MN, Compton AL. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother 2004;38:812-816.

45. Firenzuoli F, Gori L, Galapai C. Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine 2005;12(3):247-248.

46. Jordan S, Murty M, Pilon K. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. Can Adverse React Newsl 2004;14(4):3-4.

47. Health Canada warns Canadians not to use "Thermonex." Ottawa: Health Canada, 2004. www.hc-sc.gc.ca/english/protection/warnings/2004/2004_30.htm. Date accessed: November 28, 2004.

48. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001;69:14-23.

49. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and Seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A4 and p-glycoprotein. Life Sci 2002;71:1149-1160.

50. Malhotra S, Fitzsimmons ME, Bailey DG, Watkins PB. Use of Seville orange juice to "knock out" intestinal CYP3A4. Paper presented at the annual meeting of the American Association of Pharmaceutical Scientists (abstract 2091), New Orleans, LA, November 1999.

51. Hou YC, Hsiu SL, Tsao CW, Wang YH, Chao PD. Acute intoxication of cyclosporine caused by coadministration of decoctions of the fruits of Citrus aurantium and the Pericaps of Citrus grandis. Planta Med 2000;66(7):653-655.

52. Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6'7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999;65:237-244.

53. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004;76(5):428-440.

54. Keogh AM, Baron DW. Sympathomimetic abuse and coronary artery spasm. Br Med J 1985;291:940.

55. Suzuki O, Matsumoto T, Oya M, Katsumata Y. Oxidation of synephrine by type A and type B monoamine oxidase. Experientia 1979;35:1283-1284.

Keep Your Weight In Check During The Holidays

Keep Your Weight In Check During The Holidays

A time for giving and receiving, getting closer with the ones we love and marking the end of another year and all the eating also. We eat because the food is yummy and plentiful but we don't usually count calories at this time of year. This book will help you do just this.

Get My Free Ebook


Post a comment